MedPath
FDA Approval

Prepidil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 11, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Prostaglandin E2(0.5 mg in 3 g)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Pharmacia and Upjohn Company LLC

Pharmacia and Upjohn Company LLC

618054084

Pfizer Manufacturing Belgium NV

Pharmacia and Upjohn Company LLC

370156507

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Prepidil

Product Details

NDC Product Code
0009-3359
Application Number
NDA019617
Marketing Category
NDA (C73594)
Route of Administration
VAGINAL
Effective Date
December 11, 2019
Code: K7Q1JQR04MClass: ACTIBQuantity: 0.5 mg in 3 g
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACTQuantity: 240 mg in 3 g
TRIACETINInactive
Code: XHX3C3X673Class: IACTQuantity: 2760 mg in 3 g
© Copyright 2025. All Rights Reserved by MedPath